SCHMID Group N.V. is a Germany-based global supplier of capital equipment, software, and services for the printed circuit board (PCB) and substrate manufacturing industry. Headquartered in Freudenstadt and founded in 1864, the company employs more than 800 people and operates manufacturing facilities in Germany and China, along with sales and service locations worldwide. Its portfolio spans wet-process and vacuum-process equipment, automation, and after-sales services, with a strategic focus on advanced packaging, semiconductor-related applications, and AI-driven electronics. The company is also developing glass core substrate technology through a partnership with laser-technology specialist TRUMPF. Investors follow SHMD for its exposure to rising demand for AI server boards, flip-chip substrates, and next-generation glass-based advanced packaging.
Over the last 30 days, SCHMID Group shares have dropped approximately 48%, falling from a closing price of roughly $3.11 in late October to near $1.62. The decline was punctuated by a sharp rally on November 9, when the stock jumped more than 20% after the company announced a wet-process equipment order for South Asia's first glass core substrate manufacturing facility, only to surrender those gains in subsequent sessions. The quarterly picture is even weaker. From the roughly $4.37-to-$4.86 range recorded in late September, shares have declined more than 60%, pushing the stock toward the bottom of its 52-week range and into new lows. The move reflects a sustained multi-month downtrend rather than a single-event selloff, with the stock well below its 52-week high of $10.65.
The most striking feature of the last 30 days is that the stock fell despite improving operating fundamentals. On October 21, the company reported that third-quarter order intake more than doubled sequentially to €67.8 million, driven by a repeat order exceeding €37 million, and that its equipment backlog reached €96.8 million. Management also raised full-year order intake guidance to more than €150 million. Rather than rallying, shares continued to drift lower. Several factors help explain the disconnect. The company continues to report net losses and negative adjusted EBITDA, and it has been consuming cash as working capital builds toward a more normalized level. At the same time, concerns about equity dilution have intensified: share count has risen through conversions of a $30 million convertible note, with additional potential dilution from a $20 million convertible note and roughly 21 million outstanding warrants. A Schedule 13D/A filing in mid-November disclosing that the Schmid family controls a coordinated 38.84% voting bloc, and describing the company as a Nasdaq "controlled company," further highlighted the dilution and ownership concentration overhang. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last quarter, the broader narrative has been one of a balance-sheet and operating turnaround that has yet to translate into profitability or cash generation. Revenue recovered sharply in the first half of 2026, rising 172% year over year to €46.0 million, and order momentum accelerated through the third quarter on demand tied to flip-chip BGA substrate capacity and AI server boards. However, management cut its full-year adjusted EBITDA margin outlook to 6% to 9% from more than 12%, citing a product mix weighted toward lower-margin Chinese production and weaker-than-expected first-half profitability. Meanwhile, a debt-to-equity swap reduced total debt but increased the share count, and additional convertible and standby equity facilities introduced further dilution risk. The result has been a stock that has steadily repriced lower despite strong order intake, as investors weigh improving demand against ongoing losses, cash consumption, and a growing equity overhang.
Investors should monitor whether SCHMID can convert its growing order backlog into revenue while improving profitability. Full-year 2026 guidance calls for revenue of more than €100 million, an adjusted EBITDA margin of 6% to 9%, and order intake above €150 million. Key items to watch include fourth-quarter order intake, the revenue and margin mix between German and Chinese production, and progress on the company's Sprint cost-savings programs. The planned €11 million China campus expansion, expected to double local production capacity by late 2027, and the commercial adoption of glass core substrate technology are longer-term catalysts. Continued share dilution from convertible notes and warrants, working-capital trends, and cash-flow generation remain the principal risks. As always, past performance does not guarantee future results, and these observations are not investment advice.
In my own work, I find Tickeron’s AI Trading Bots helpful for testing systematic approaches on volatile names like this one. The platform lets me compare different bot strategies and holding periods side by side, which adds a useful data layer to the fundamental picture without replacing it.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
The Aroon Indicator for SHMD entered a downward trend on November 19, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 124 similar instances where the Aroon Indicator formed such a pattern. In 108 of the 124 cases the stock moved lower. This puts the odds of a downward move at 87%.
The Moving Average Convergence Divergence Histogram (MACD) for SHMD turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 64 similar instances when the indicator turned negative. In 31 of the 64 cases the stock turned lower in the days that followed. This puts the odds of success at 48%.
The 10-day moving average for SHMD crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where SHMD advanced for three days, in 99 of 161 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
SHMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.561) is normal, around the industry mean (3.843). P/E Ratio (-0.914) is within average values for comparable stocks, (36.971). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (1.966) is also within normal values, averaging (189.487).
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. SHMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry IndustrialMachinery